Skip to main content

Table 2 Laboratory data of the study subjects pre-IVIG treatment

From: Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease

Parameter

repeated IVIG-responsive group

(n = 54)

repeated IVIG-resistant group

(n = 40)

p

WBC count (×10 9 /L)

16.51(10.25 ~ 20.59)

15.39(11.07 ~ 17.74)

0.807

 N%

73.50(70.50 ~ 86.60)

84.60(74.97 ~ 89.15)

0.017*

Hb (g/L)

110(96 ~ 121)

103(92 ~ 115)

0.061

PLT (×10 9 /L)

284(215 ~ 381)

264(190 ~ 339)

0.173

CRP (mg/L)

106.5(73.0 ~ 141.0)

114.0(83.8 ~ 166.5)

0.119

ESR(mm/h)

81.0(52.0 ~ 100.0)

86.5(65.8 ~ 119.5)

0.338

ALT (U/L)

61.4(17.0 ~ 153.6)

66.0(28.0 ~ 136.9)

0.482

AST (U/L)

67.1(35.9 ~ 133.9)

41.5(33.2 ~ 97.7)

0.178

Na+ (mmol/L)

135.0(133.8 ~ 137.8)

133.0(130.3 ~ 136.9)

0.006*

ALB (g/L)

33.5(30.2 ~ 37.1)

30.2(29.3 ~ 33.3)

0.001*

TB (umol/L)

12.6(9.8 ~ 17.8)

14.9(11.4 ~ 18.9)

0.167

Creatinine (umol/L)

30.8(26.7 ~ 35.0)

32(29.0 ~ 35.8)

0.234

Urea nitrogen (mmol/L)

3.19(2.79 ~ 3.49)

3.33(2.83 ~ 3.90)

0.063

APTT(s)

47.8(43.5 ~ 52.5)

44.6(41.2 ~ 52.5)

0.351

PT(s)

15.3(14.5 ~ 16.8)

16.0(15.4 ~ 16.7)

0.052

D-dimer (ug/ml)

1.92(1.36 ~ 3.88)

2.34(1.44 ~ 3.89)

0.204

PCT (ng/ml)

1.40(0.99 ~ 2.84)

3.81(1.90 ~ 10.51)

< 0.001*

NT-proBNP(pg/ml)

487.1(182.3 ~ 763.9)

669.8(303.5 ~ 1493.8)

0.015*

  1. *Statistically significant (P < 0.05)
  2. WBC white blood cell, Hb hemoglobin, PLT platelet, N% percentage of neutrophils, CRP C-reactive protein, ESR erythrocyte sedimentation rate, ALT alanine aminotransferase, AST aspartate transaminase, Na+ serum sodium, ALB albumin, TB total bilirubin, APTT activated partial thromboplastin time, PT prothrombin time, PCT procalcitonin, NT-proBNP N-terminal pro-brain natriuretic peptide